Alere to Report Second Quarter 2015 Financial Results on August 4, 2015

Jul 28, 2015, 07:00 ET from Alere Inc.

WALTHAM, Mass., July 28, 2015 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that it will release its financial results for the second quarter ended June 30, 2015. The Company will host a conference call beginning at 8:30 a.m. ET on Tuesday, August 4, 2015, to discuss these results and provide business updates.

The conference call will be webcast live on the Investor Relations section of Alere's website, or accessed directly through the following link:

https://www.webcaster4.com/Webcast/Page/411/9606

To access the conference call, please use the following dial-in numbers and access code 1496673:

  • US (toll-free): 1-888-317-6003
  •  International: 1-412-317-6061
  • Canada (toll-free): 1-866-284-3684

A replay will be available approximately one hour after the conclusion of the call and will remain available for a period of seven days following the call. To hear a replay of the conference call, please use the following dial-in numbers and replay code 10069486 (available for seven days):

  • US (toll-free): 1-877-344-7529
  • International: 1-412-317-0088
  • Canada (toll-free): 1-855-669-9658

The replay will also be available via online webcast on the Investor Relations section of the Alere website.

During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

About Alere Alere believes that when diagnosing and monitoring health conditions, Knowing now matters™. Alere delivers on this vision by delivering reliable and actionable information through rapid diagnostic tests, enhancing clinical and economic health outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology. For more information on Alere, please visit www.alere.com.

SOURCE Alere Inc.



RELATED LINKS

http://www.alere.com